Here we are, on the cusp of the midway point in a decade that has been, in global health and infectious diseases terms, a lot ...

STAT '3 to Watch' series looks at biotech industry issues in 2025: Trump administration uncertainties, pharma deals in China, ...

In STAT's "jealousy list" for 2024, STAT staffers explain what makes a selection of stories they read in other publications ...

Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to ...

The killing of UnitedHealthcare CEO Brian Thompson has sparked extraordinary public interest in the nation’s health insurance ...

After multiple short-term extensions, telehealth providers are eager for Congress to lay out its long-term plans for the ...

Retractions are meant to maintain trust in science — but on social media, they're often used to reinforce anti-science bias ...

Bone marrow transplants, long a mainstay of blood cancer treatments, are becoming less common in favor of options like CAR-T ...

It is time for us to dispel the darkness of our health care industry through the light of integrity and compassion,” writes ...

U.S. senators and other lawmakers argue the problems created by UnitedHealth's size and reach demand steps to restore public ...

This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox every Monday. Sign up here. ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.